Medication-related Osteonecrosis of the Jaw and Dental Implant: A Case Report
Authors:
- Zhukova Natalia AlexandrovnaZAZhukova Natalia Alexandrovna
- Dymnikov BorisovichDBDymnikov Borisovich
- Hassan Alsayed HachemHHHassan Alsayed Hachem
- Zaderenko Igor AlexandrovichZAZaderenko Igor Alexandrovich
- Nada Ahmed Mohamed Elsayed TahaNTNada Ahmed Mohamed Elsayed Taha
- Liu MingyuLMLiu Mingyu
- Aalyasir Ayoob Wahhab FahadAFAalyasir Ayoob Wahhab Fahad
- Ziad AlbashZAZiad Albash
Open Access
- 1 April 2026
- journal article
- Published by Bentham Science Publishers Ltd. in The Open Dentistry Journal
- Vol. 20 (1)
Abstract
Introduction/Background: The rising use of anti-resorptive agents, including denosumab, for bone metastases has led to an increased incidence of medication-related osteonecrosis of the jaw. This particular case represents an important, but also often overlooked, potential late sequelae that may be seen in cancer patients, which is the failure of a previously well-functioning dental implant years down the line, which may then become a causative factor for MRONJ. Case Presentation: A 70-year-old female patient, a chronic user of high-dose denosumab for metastatic breast carcinoma, presented with pain and infection of the mandibular implant, which was functionally osseointegrated for seven years before the onset of symptoms. The patient was evaluated and was found to have a bony sequestrum containing the implant, meaning the diagnosis was a Stage 2 MRONJ. Conservative management was ineffective; thus, surgical intervention involving sequestrectomy and removal of the implant en bloc was performed. Conclusion: This case of treating the patient also shows us that patients undergoing any treatment with denosumab, who have dental implants, are continuously at risk of late-onset MRONJ and hence need long-term surveillance, and thereby, more emphasis needs to be placed on giving them informed consent for such a lifelong risk of acquiring the disease. Thus, great care must be taken before performing any such surgical procedure. This case also shows that the surgery has been successful in treating the patient, without the need to withdraw any ongoing antiresorptive drugs.Keywords
This publication has 26 references indexed in Scilit:
- Medication-Related osteonecrosis of the jaw involving dental implants: A 16-Year observational study in a single cancer centerClinical Oral Investigations, 2025
- Dental Implant Failure and Medication-Related Osteonecrosis of the Jaw Related to Dental Implants in Patients Taking Antiresorptive Therapy for Osteoporosis: A Systematic Review and Meta-AnalysisEndocrine Practice, 2025
- Analysis of prosthetic risk factors for peri-implant medication-related osteonecrosis of the jaw: an observational studyScientific Reports, 2025
- Cumulative incidence and risk factors for medication-related osteonecrosis of the jaw during long-term prostate cancer managementScientific Reports, 2024
- American Association of Oral and Maxillofacial Surgeons’ Position Paper on Medication-Related Osteonecrosis of the Jaws—2022 UpdateJournal of Oral and Maxillofacial Surgery, 2022
- Medication‐related dental implant failure: Systematic review and meta‐analysisClinical Oral Implants Research, 2018
- Bisphosphonate-related osteonecrosis of the jaw: a mechanobiology perspectiveBone Reports, 2018
- Effects of an oral bisphosphonate and three intravenous bisphosphonates on several cell types in vitroClinical Oral Investigations, 2018
- Medication-Related Osteonecrosis of the Jaw Around Dental ImplantsJournal of Craniofacial Surgery, 2016
- Osteoporosis in the European Union: medical management, epidemiology and economic burdenArchives of Osteoporosis, 2013